Abstract
Fallopian tube carcinoma (FTC) is a rare but lethal gynaecological malignancy. Four out of seven FTCs were identified with three point missense mutations, one single base deletion and one silent point mutation in the p53 gene. Genital-type HPV sequences were not detected. The S-phase fraction of tumours with mutant and wild-type p53 was 25.74% (median) and 12.55% (median) respectively.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Runnebaum, I., Köhler, T., Stickeler, E. et al. p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma. Br J Cancer 74, 1157–1160 (1996). https://doi.org/10.1038/bjc.1996.510
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.510
This article is cited by
-
Primary fallopian tube cancer: a review of the literature
Medical Oncology (1998)